Evidence map›Paper›PMID 39530498›Full record

ReviewMass spectrometry reviews

A Perspective of Multi-Reflecting TOF MS.

A N Verenchikov, V V Makarov, A V Vorobyev, S N Kirillov

Abstract readReview
In one paragraph

Review in Mass spectrometry reviews. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. A Novel Compact Multi-Reflecting Time-of-Flight Mass Spectrometer.Journal of the American Society for Mass Spectrometry · 2026
    Article
  4. Article
  5. Article
  6. Mass Spectrometry Imaging.Analytical chemistry · 2025
    Review
  7. Top-Down and Middle-Down Mass Spectrometry of Antibodies.Molecular & cellular proteomics : MCP · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

A N VerenchikovMass Spectrometry Consulting Ltd, City of Bar, Montenegro.ORCID http://orcid.org/0000-0002-0344-5633
V V MakarovMass Spectrometry Consulting Ltd, City of Bar, Montenegro.ORCID http://orcid.org/0009-0009-3163-5467
A V VorobyevMass Spectrometry Consulting Ltd, City of Bar, Montenegro.ORCID http://orcid.org/0009-0005-6067-3383
S N KirillovMass Spectrometry Consulting Ltd, City of Bar, Montenegro.ORCID http://orcid.org/0009-0003-2062-8145

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Time-of-flight mass spectrometry (TOF MS) excels in rapid and high-sensitivity analysis, making it a cornerstone of analytical chemistry. But as sample complexity explodes in omics studies, so does the need for higher resolving power to ensure accurate results. Traditional TOF instruments face a challenge: achieving high resolution often requires a very large instrument. To overcome this limitation, scientists developed alternative designs for TOF analyzers called multi-pass TOF analyzers (MPT). These MPT analyzers come in two main configurations: multi-turn (MTT) and multi-reflecting (MRT). Drawing on the authors' extensive experience, this review describes two decades of MPT advancements. It highlights the critical development of optimized analyzer designs, tracing the evolution towards mirror-based MRT instruments, generally providing superior resolution and spatial acceptance compared to MTT. While the manuscript attempts to overview MTT advances, it primarily focuses on MRT technology. Additionally, the review explores the role of orthogonal accelerators and trap pulse converters, comparing their efficiency and the dynamic range limits imposed by space charge effects. By comparing various MRT configurations and commercially available instruments, the review sets out to inform and empower researchers so they can make informed decisions about MRT mass spectrometers.

Identifiers

PMID39530498
PMCPMC13062609

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.